| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5980882 | RB HLTH | Drug-resin complexes stabilized by chelating agents |
Apr, 2017
(7 years ago) | |
Delsym is owned by Rb Hlth.
Delsym contains Dextromethorphan Polistirex.
Delsym has a total of 1 drug patent out of which 1 drug patent has expired.
Expired drug patents of Delsym are:
- US5980882
Delsym was authorised for market use on 08 October, 1982.
Delsym is available in suspension, extended release;oral dosage forms.
The generics of Delsym are possible to be released after 16 April, 2017.
Drugs and Companies using DEXTROMETHORPHAN POLISTIREX ingredient
Market Authorisation Date: 08 October, 1982
Treatment: NA
Dosage: SUSPENSION, EXTENDED RELEASE;ORAL
How can I launch a generic of DELSYM before it's drug patent expiration?
More Information on Dosage
DELSYM family patents
